Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Dow
Harvard Business School
Fish and Richardson
Moodys
Daiichi Sankyo
Queensland Health
Cerilliant
Federal Trade Commission

Generated: November 15, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: nilotinib hydrochloride

« Back to Dashboard

nilotinib hydrochloride

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0526-51 28 CAPSULE in 1 BLISTER PACK (0078-0526-51)
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0526-87 4 BLISTER PACK in 1 CARTON (0078-0526-87) > 28 CAPSULE in 1 BLISTER PACK
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0592-51 28 CAPSULE in 1 BLISTER PACK (0078-0592-51)
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0592-87 4 BLISTER PACK in 1 CARTON (0078-0592-87) > 28 CAPSULE in 1 BLISTER PACK
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Covington
Merck
UBS
Queensland Health
US Army
Citi
Farmers Insurance
Chubb